Journey Medical Corp
NASDAQ:DERM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Journey Medical Corp (DERM) under the Base Case is 12.63 USD per share.
Compared with the current market price of 4.33 USD, the stock appears
Undervalued by 66% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Journey Medical Does
Journey Medical Corp is a specialty pharmaceutical company focused on prescription medicines for skin conditions. It sells treatments used by dermatologists and other prescribers for problems such as acne, fungal infections, rosacea, and other common dermatology needs. Its products are sold through pharmacies to patients after a doctor writes a prescription.
- Headquarters
- United States of America US
- Employees
- 58
- IPO date
- Nov 12, 2021
Earnings Waterfall
Journey Medical Corp
What is the Intrinsic Value of one DERM stock?
The intrinsic value for Journey Medical Corp (DERM) under the Base Case is 12.63 USD.
Is DERM stock undervalued or overvalued?
Compared with the current market price of 4.33 USD, the stock appears Undervalued by 66% .
